Investor Says Biotech Co. Hid Blood Treatment Funding Woes

By Ryan Harroff · January 5, 2023, 5:46 PM EST

Israeli biotechnology company BioLine misled the public and its shareholders about its financing shortfalls for a new blood therapy, then ultimately caused a 33% stock drop when it made moves to...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

IN RE BIOLINERX LTD. SECURITIES LITIGATION

Case Number

2:23-cv-00041

Court

New Jersey

Nature of Suit

Securities/Commodities

Date Filed

January 05, 2023